Literature DB >> 29029203

Prognostic significance of computed tomography criteria for pulmonary veno-occlusive disease in systemic sclerosis-pulmonary arterial hypertension.

Michelle J Connolly1, Sharif Abdullah2, Deborah A Ridout3, Benjamin E Schreiber1, Jamanda A Haddock2, J Gerry Coghlan1.   

Abstract

Objectives: SSc-pulmonary arterial hypertension (SSc-PAH) is associated with worse response to therapy and survival when compared with idiopathic PAH. It is suggested that the vasculopathy in SSc may involve postcapillary pulmonary venules resulting in pulmonary veno-occlusive disease (PVOD). This may underlie the lower gas transfer and worse outcome on therapy. We sought to test whether CT signs of PVOD (CTS-PVOD) were frequent in SSc-PAH and whether they were associated with pulmonary oedema on therapy and worse survival.
Methods: CT thorax of 66 SSc patients with precapillary pulmonary hypertension (PH) were blindly scored by two radiologists for CTS-PVOD (⩽1 or ⩾ 2). Case note and radiograph review determined the presence of pulmonary oedema on therapy.
Results: Fifty-nine patients (89%) had ⩽1 CTS-PVOD and only 7 (11%) had ⩾2 CTS-PVOD. Pulmonary oedema on therapy was relatively common in those with ⩾2 CTS-PVOD. On univariate analysis ⩾2 CTS-PVOD were associated with a trend towards worse survival.
Conclusion: CTS-PVOD were less frequent in this SSc-PAH cohort than in previous reports but the presence of at least two of these signs is associated with pulmonary oedema on therapy and a trend towards worse survival on univariate analysis.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  computed tomography; pulmonary arterial hypertension; pulmonary veno-occlusive disease; systemic sclerosis; systemic sclerosis-pulmonary arterial hypertension

Mesh:

Year:  2017        PMID: 29029203     DOI: 10.1093/rheumatology/kex351

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  6 in total

Review 1.  Aggressive combination therapy for treatment of systemic sclerosis-associated pulmonary hypertension.

Authors:  J G Coghlan; Christopher P Denton
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

Review 2.  Pulmonary arterial hypertension in systemic sclerosis: Diagnosis and treatment according to the European Society of Cardiology and European Respiratory Society 2015 guidelines.

Authors:  Nicola Giordano; Claudio Corallo; Chiara Chirico; Angelica Brazzi; Adriana Marinetti; Antonella Fioravanti; Roberto Valenti; Ranuccio Nuti; Gianluca Pecetti
Journal:  J Scleroderma Relat Disord       Date:  2018-11-14

Review 3.  The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis.

Authors:  Michael H Lee; Todd M Bull
Journal:  F1000Res       Date:  2019-12-19

4.  Pulmonary veno-occlusive disease in a patient with recently diagnosed systemic sclerosis.

Authors:  Nina M van Leeuwen; Sofia Ramiro; Maarten K Ninaber; Esther Nossent; Jeska K de Vries-Bouwstra
Journal:  J Scleroderma Relat Disord       Date:  2019-06-07

Review 5.  Computed tomography appearances of the lung parenchyma in pulmonary hypertension.

Authors:  Robert W Foley; Nirav Kaneria; Rob V MacKenzie Ross; Jay Suntharalingam; Benjamin J Hudson; Jonathan Cl Rodrigues; Graham Robinson
Journal:  Br J Radiol       Date:  2020-09-11       Impact factor: 3.039

Review 6.  An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients.

Authors:  Barbara Ruaro; Francesco Salton; Elisa Baratella; Paola Confalonieri; Pietro Geri; Riccardo Pozzan; Chiara Torregiani; Roberta Bulla; Marco Confalonieri; Marco Matucci-Cerinic; Michael Hughes
Journal:  Diagnostics (Basel)       Date:  2022-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.